References

Agostinetto, R., Rossi, M., Dawson, J., Lim, A., Simoneau, M.H., Boucher, C., . Dey, A.K. (2022). Rapdi cGMP manufacturing of COVID-19 monoclonal antibody using stable CHO cell pools. Biotech. Bioeng., 199(2), 663-666. https:/doi.10.1002/bit.27995
Bleck, G. (2006). An Alternative Method for the Rapid Generation of Stable, High-Expressing Mammalian Cell Lines. BioProcessing Journal, 5(4). https://doi.org/10.12665/j54.bleck
Bleck, G. (2012). Consistent production of genetically stable mammalian cell lines. BioPharm International-05-01-2012, Volume 25, Issue 5
D’haene, B., Vandesompele, J., & Hellemans, J. (2010). Accurate and objective copy number profiling using real-time quantitative PCR. In Methods (Vol. 50, Issue 4). https://doi.org/10.1016/j.ymeth.2009.12.007
Feary, M., Moffat, M. A., Casperson, G. F., Allen, M. J., & Young, R. J. (2021). CHOK1SV GS-KO SSI expression system: A combination of the Fer1L4 locus and glutamine synthetase selection. Biotechnology Progress, 37(4). https://doi.org/10.1002/btpr.3137
Grandjean, M., Girod, P. A., Calabrese, D., Kostyrko, K., Wicht, M., Yerly, F., Mazza, C., Beckmann, J. S., Martinet, D., & Mermod, N. (2011). High-level transgene expression by homologous recombination-mediated gene transfer. Nucleic Acids Research, 39(15). https://doi.org/10.1093/nar/gkr436
Kravitz, R., Vredenburgh, W., Chrostowski, V., & Bleck, G. (2019). Achieving Unique Synergies in Antibody Expression. Genetic Engineering & Biotechnology News, 39(7), 55–57. https://doi.org/10.1089/gen.39.07.16
Mitchell, R. S., Beitzel, B. F., Schroder, A. R. W., Shinn, P., Chen, H., Berry, C. C., Ecker, J. R., & Bushman, F. D. (2004). Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biology, 2(8). https://doi.org/10.1371/journal.pbio.0020234
Ng, D., Zhou, M., Zhan, D., Yip, S., Ko, P., Yim, M., Modrusan, Z., Joly, J., Snedecor, B., Laird, M. W., & Shen, A. (2021). Development of a targeted integration Chinese hamster ovary host directly targeting either one or two vectors simultaneously to a single locus using the Cre/Lox recombinase-mediated cassette exchange system. Biotechnology Progress, 37(4). https://doi.org/10.1002/btpr.3140
Rajendra, Y., Balasubramanian, S., McCracken, N. A., Norris, D. L., Lian, Z., Schmitt, M. G., Frye, C. C., & Barnard, G. C. (2017). Evaluation of piggyBac-mediated CHO pools to enable material generation to support GLP toxicology studies. Biotechnology Progress, 33(6), 1436–1448. https://doi.org/10.1002/btpr.2495
Rajendran, S., Balasubramanian, S., Webster, L., Lee, M., Vavilala, D., Kulikov, N., Choi, J., Tang, C., Hunter, M., Wang, R., Kaur, H., Karunakaran, S., Sitaraman, V., Minshull, J., & Boldog, F. (2021). Accelerating and de-risking CMC development with transposon-derived manufacturing cell lines. Biotechnology and Bioengineering, 118(6), 2301–2311. https://doi.org/10.1002/bit.27742
Schmieder, V., Fieder, J., Drerup, R., Gutierrez, E. A., Guelch, C., Stolzenberger, J., Stumbaum, M., Mueller, V. S., Higel, F., Bergbauer, M., Bornhoefft, K., Wittner, M., Gronemeyer, P., Braig, C., Huber, M., Reisenauer-Schaupp, A., Mueller, M. M., Schuette, M., Puengel, S., … Fischer, S. (2022). Towards maximum acceleration of monoclonal antibody development: Leveraging transposase-mediated cell line generation to enable GMP manufacturing within 3 months using a stable pool. Journal of Biotechnology, 349, 53–64. https://doi.org/10.1016/j.jbiotec.2022.03.010
Stuible, M., van Lier, F., Croughan, M.S., Durocher, Y. (2018). Beyond preclinical research: production of CHO-derived biotherapeutics for toxicology and early-phase trials by transient gene expression or stable pools. Curr. Opin. Chem. Eng., 22, 145-151. https:/doi.org/10.1016/j.coche.2018.09.010
Thyagarajan, B., & Calos, M. P. (2005). Site-specific integration for high-level protein production in mammalian cells. In Therapeutic Proteins (pp. 99-106). Humana Press.
Wu, X., Li, Y., Crise, B., & Burgess, S. M. (2003). Transcription start regions in the human genome are favored targets for MLV integration. Science, 300(5626). https://doi.org/10.1126/science.1083413
Xu, G., Yu, C., Wang, W., Fu, C., Liu, H., Zhu, Y., Li, Y., Liu, C., Fu, Z., Wu, G., Li, M., Guo, S., Yu, X., Du, J., Yang, Y., Duan,
M., Cui, Y., Feng, H., Wang, L. (2022). Quality comparability assessment of a SARS-CoV-2-neutralizing antibody across transient, mini-pool-derived and single-clone CHO cells. MABS, 14 (1), e2005507. https://doi.org/10.1080/19420862.2021.2005507
Zhang, Z., Chen, J., Wang, J., Gao, Q., Ma, Z., Xu, S., … Zhou, W. (2021). Reshaping cell line development and CMC strategy for fast responses to pandemic outbreak. Biotech. Prog., 37 (5), e3186. http//doi.org/10.1002/btpr.3186